The use of GLP-1 agonists is associated with a number of potential gastrointestinal side effects, the most common being nausea, vomiting, diarrhea, and constipation
Fibromyalgia is another condition characterized by widespread musculoskeletal pain and profound fatigue, often linked to sleep disturbances and stress
Discontinuation rate: 13% Wegovy , 27% placebo
Elsevier, p 1616 Punzo A, Silla A, Fogacci F, Perillo M, Cicero AFG, Caliceti C (2024) Bile acids and bilirubin role in oxidative stress and inflammation in cardiovascular diseases
NIH/PMC Tri-agonism is founded on the following approach: GLP-1 receptor agonism modulates energy balance, which glucagon receptor agonism enhances through supplementary mechanisms, while GLP-1 and GIP receptor agonism stimulates insulin secretion and protects against hyperglycemic risk
/